We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SLAB:NASDAQSilicon Laboratories, Inc. Analysis

Data as of 2026-06-11 - not real-time

$217.81

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Technical outlook: The stock is trading just above its 20‑day simple moving average and comfortably above the 50‑day SMA, confirming a short‑term bullish bias. Momentum indicators are mixed – RSI sits in the mid‑50s, while the MACD histogram has turned negative, hinting at emerging bearish pressure near the current resistance level. The price is hugging a tight support zone just above $215, and volume remains stable despite a daily volume far below its 10‑day average, suggesting limited immediate upside.
Fundamental backdrop: Revenue is expanding at roughly 20% year‑over‑year, driven by strong demand in IoT and industrial applications, and the balance sheet is solid with ample cash and zero debt. However, operating and profit margins remain negative, and free cash flow is modest. A discounted cash‑flow model places intrinsic value far below the market price, while the forward PE sits well above the industry average, signaling that the market is pricing in high growth expectations amid an “Extreme Greed” sentiment environment.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near immediate resistance with bearish MACD histogram
  • Stable but low trading volume limiting short‑term catalysts
  • Support level provides downside cushion

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Strong revenue growth in IoT and industrial segments
  • Continued negative operating margins and modest free cash flow
  • Market pricing reflects high growth expectations despite DCF undervaluation

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Robust cash position and zero debt supporting strategic investments
  • Secular tailwinds in semiconductor demand for mixed‑signal and analog solutions
  • Forward earnings outlook turning positive, offering upside if valuation compresses

Key Metrics & Analysis

Financial Health

Revenue Growth20.10%
Profit Margin-6.13%
P/E Ratio52.5
ROE-4.65%
ROA-2.78%
P/B Ratio6.5
Op. Cash Flow$52.5M
Free Cash Flow$15.4M
Industry P/E35.9

Technical Analysis

TrendBullish
RSI54.2
Support$215.02
Resistance$219.68
MA 20$217.87
MA 50$215.59
MA 200$168.71
MACDBearish
VolumeStable
Fear & Greed Index83.2

Valuation

Fair Value$27.17
Target Price$222.86
Upside/Downside2.32%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta0.98
Volatility5.54%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.